Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorSILVA, Clovis A.-
dc.contributor.authorAIKAWA, Nadia E.-
dc.contributor.authorBONFA, Eloisa-
dc.identifier.citationNATURE REVIEWS RHEUMATOLOGY, v.9, n.9, p.532-543, 2013-
dc.description.abstractVaccination is a powerful tool to reduce the burden of infectious diseases in paediatric patients with chronic rheumatic diseases. Live attenuated vaccines are not recommended for profoundly immunosuppressed patients, but nonlive vaccines have adequate safety and efficacy profiles in the few (admittedly underpowered) studies published to date. No severe vaccine-specific or disease-specific adverse events have been observed in patients with juvenile idiopathic arthritis (JIA) or childhood-onset systemic lupus erythematosus (SLE) who have been vaccinated with live or nonlive agents. The immune response to live vaccines is variable in these patients but generally adequate, despite concomitant use of immunosuppressive and biologic agents. The proposal that onset of autoimmune rheumatic diseases could be induced by vaccination is controversial and primarily based on case reports; however, patients with mevalonate kinase deficiency can experience febrile attacks after immunizations. Adequately powered studies of live and nonlive vaccination in patients with paediatric rheumatic diseases are necessary to clarify safety and efficacy issues. This narrative Review discusses vaccination in patients with JIA, childhood-onset SLE, juvenile dermatomyositis, juvenile systemic sclerosis, primary vasculitis and autoinflammatory syndromes. Vaccine safety, short-term and long-term changes in disease parameters, and the immunogenicity and influence of immunosuppressive agents are outlined for each combination of disease and vaccine.-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2008/58238-4, FAPESP 11/12471-2, FAPESP 09/51897-5, FAPESP 10/10749-0]-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq302724/2011-7, CNPq472155/2012-1, CNPq301411/2009-3]-
dc.description.sponsorshipNucleo de Apoio a Pesquisa ""Saude da Crianca e do Adolescente"" da USP-
dc.description.sponsorshipFederico Foundation-
dc.relation.ispartofNature Reviews Rheumatology-
dc.subject.otherhenoch-schonlein purpura-
dc.subject.otherincomplete kawasaki-disease-
dc.subject.otherhepatitis-b vaccination-
dc.subject.othert-cell response-
dc.subject.otheridiopathic arthritis-
dc.subject.otherinfluenza vaccination-
dc.subject.othervaricella vaccine-
dc.subject.otherantiphospholipid antibodies-
dc.titleVaccinations in juvenile chronic inflammatory diseases: an update-
dc.rights.holderCopyright NATURE PUBLISHING GROUP-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.relation.referenceAikawa NE, 2013, SCAND J RHEUMATOL, V42, P34, DOI 10.3109/03009742.2012.709272-
hcfmusp.relation.referenceAikawa NE, 2012, J RHEUMATOL, V39, P167, DOI 10.3899/jrheum.110721-
hcfmusp.relation.referenceAltman A, 2008, RHEUMATOL INT, V28, P609, DOI 10.1007/s00296-007-0485-4-
hcfmusp.relation.referenceAmerican Academy of Pediatrics, 2003, RED BOOK 2003 REP CO, P672-
hcfmusp.relation.referenceAntony D, 2005, INDIAN PEDIATR, V42, P83-
hcfmusp.relation.referenceAytac MB, 2011, CLIN EXP RHEUMATOL, V29, P882-
hcfmusp.relation.referenceBarbosa CMPL, 2012, CLIN EXP RHEUMATOL, V30, P791-
hcfmusp.relation.referenceBenmously Mlika Rym, 2010, J Am Acad Dermatol, V63, P1111, DOI 10.1016/j.jaad.2009.02.047-
hcfmusp.relation.referenceBodar EJ, 2005, NETH J MED, V63, P260-
hcfmusp.relation.referenceBodar EJ, 2011, ANN RHEUM DIS, V70, P2155, DOI 10.1136/ard.2011.149922-
hcfmusp.relation.referenceBodewes R, 2012, EXPERT REV VACCINES, V11, P963, DOI 10.1586/ERV.12.69-
hcfmusp.relation.referenceBorte S, 2009, RHEUMATOLOGY, V48, P144, DOI 10.1093/rheumatology/ken436-
hcfmusp.relation.referenceCampos L. M., ARTHRITIS C IN PRESS-
hcfmusp.relation.referenceCarneiro-Sampaio M, 2007, ADV IMMUNOL, V95, P51, DOI 10.1016/S0065-2776(07)95002-6-
hcfmusp.relation.referenceCenter KJ, 2009, PEDIATR INFECT DIS J, V28, P438, DOI [10.1097/INF.0b013e318196934a, 10.1097/INF.0b013e318196394a]-
hcfmusp.relation.referenceChalmers D, 2008, J PAEDIATR CHILD H, V44, P525, DOI 10.1111/j.1440-1754.2008.01364.x-
hcfmusp.relation.referenceCOTTERILL JA, 1978, LANCET, V2, P1158-
hcfmusp.relation.referenceCourtney PA, 2001, RHEUMATOLOGY, V40, P345, DOI 10.1093/rheumatology/40.3.345-
hcfmusp.relation.referenceCush J. J., 2008, HERPES ZOSTER SHINGL-
hcfmusp.relation.referenceDavies K, 2002, RHEUMATOLOGY, V41, P937, DOI 10.1093/rheumatology/41.8.937-
hcfmusp.relation.referenceDell'Era L, 2011, RHEUMATOLOGY, V50, P1358, DOI 10.1093/rheumatology/ker102-
hcfmusp.relation.referenceDell'Era L, 2012, VACCINE, V30, P936, DOI 10.1016/j.vaccine.2011.11.083-
hcfmusp.relation.referenceDhiman N, 2005, CLIN EXP IMMUNOL, V142, P498, DOI 10.1111/j.1365-2249.2005.02931.x-
hcfmusp.relation.referenceEHRENGUT W, 1978, LANCET, V1, P1040-
hcfmusp.relation.referenceEMA, 2004, GUID DOSS STRUCT CON-
hcfmusp.relation.referenceEMA. Committee for Proprietary Medicinal Products, 1997, NOT GUID HARM REQ IN-
hcfmusp.relation.referenceErguven M, 2011, J CHIN MED ASSOC, V74, P205, DOI 10.1016/j.jcma.2011.03.004-
hcfmusp.relation.referenceFarmaki E, 2010, VACCINE, V28, P5109, DOI 10.1016/j.vaccine.2010.03.080-
hcfmusp.relation.referenceFrenck RW, 2010, ARTHRIT CARE RES, V62, P903, DOI 10.1002/acr.20234-
hcfmusp.relation.referenceGoodman M. J., 2010, PEDIATRICS, V126, P325-
hcfmusp.relation.referenceGriffith LM, 2009, J ALLERGY CLIN IMMUN, V124, P1152, DOI 10.1016/j.jaci.2009.10.022-
hcfmusp.relation.referenceGuissa VR, 2012, CLIN EXP RHEUMATOL, V30, P583-
hcfmusp.relation.referenceHeijstek MW, 2007, ANN RHEUM DIS, V66, P1384, DOI 10.1136/ard.2006.063586-
hcfmusp.relation.referenceHeijstek MW, 2011, ANN RHEUM DIS, V70, P1704, DOI 10.1136/ard.2011.150193-
hcfmusp.relation.referenceHeijstek MW, 2012, ANN RHEUM DIS, V71, P948, DOI 10.1136/annrheumdis-2011-200637-
hcfmusp.relation.referenceHeijstek MW, 2011, AUTOIMMUN REV, V11, P112, DOI 10.1016/j.autrev.2011.08.010-
hcfmusp.relation.referenceHSU YH, 1987, PEDIATR INFECT DIS J, V6, P576-
hcfmusp.relation.referenceHua W., 2009, PEDIATR INFECT DIS J, V28, P943-
hcfmusp.relation.referenceJanow G, 2012, NAT REV RHEUMATOL, V8, P188, DOI 10.1038/nrrheum.2012.13-
hcfmusp.relation.referenceKanakoudi-Tsakalidou F, 2001, CLIN EXP RHEUMATOL, V19, P589-
hcfmusp.relation.referenceKasapcopur O, 2004, ANN RHEUM DIS, V63, P1128, DOI 10.1136/ard.2003.013201-
hcfmusp.relation.referenceKashef Sara, 2008, Iran J Immunol, V5, P181, DOI IJIv5i3A7-
hcfmusp.relation.referenceKASS E, 1979, SCAND J RHEUMATOL, V8, P187-
hcfmusp.relation.referenceKhaled A, 2012, PEDIATR DERMATOL, V29, P525, DOI 10.1111/j.1525-1470.2011.01548.x-
hcfmusp.relation.referenceKiray E, 2009, J RHEUMATOL, V36, P2029, DOI 10.3899/jrheum.090173-
hcfmusp.relation.referenceKorematsu S, 2009, VACCINE, V27, P5041, DOI 10.1016/j.vaccine.2009.06.052-
hcfmusp.relation.referenceKuniyuki S, 1997, J AM ACAD DERMATOL, V37, P303, DOI 10.1016/S0190-9622(97)80376-3-
hcfmusp.relation.referenceLambert EM, 2003, PEDIATRICS, V112, pE491, DOI 10.1542/peds.112.6.e491-
hcfmusp.relation.referenceLINNEMANN CC, 1975, ANN RHEUM DIS, V34, P354, DOI 10.1136/ard.34.4.354-
hcfmusp.relation.referenceLong CB, 2012, J PEDIATR-US, V160, P74, DOI 10.1016/j.jpeds.2011.06.045-
hcfmusp.relation.referenceMALLESON PN, 1993, J RHEUMATOL, V20, P1769-
hcfmusp.relation.referenceMcCann LJ, 2007, ARCH DIS CHILD, V92, P366, DOI 10.1136/adc.2006.112805-
hcfmusp.relation.referenceMiller Michael A, 2012, Adv Pediatr, V59, P95, DOI 10.1016/j.yapd.2012.04.017-
hcfmusp.relation.referenceMiraglia J. L., 2011, PLOS ONE, V6, P27214-
hcfmusp.relation.referenceMiron D, 2003, CLIN RHEUMATOL, V22, P461, DOI 10.1007/s10067-003-0785-3-
hcfmusp.relation.referenceMiyamoto M, 2011, LUPUS, V20, P736, DOI 10.1177/0961203310397409-
hcfmusp.relation.referenceMorin MP, 2012, RHEUMATOLOGY, V51, P2046, DOI 10.1093/rheumatology/kes175-
hcfmusp.relation.referenceMormile R, 2004, VACCINE, V23, P567, DOI 10.1016/j.vaccine.2004.07.029-
hcfmusp.relation.referenceOgimi C, 2011, PEDIATR INFECT DIS J, V30, P208, DOI 10.1097/INF.0b013e3181f7ce44-
hcfmusp.relation.referenceOLSON NY, 1994, J RHEUMATOL, V21, P1581-
hcfmusp.relation.referenceOZAKI T, 1989, Acta Paediatrica Japonica, V31, P484-
hcfmusp.relation.referencePileggi GS, 2010, ARTHRIT CARE RES, V62, P1034, DOI 10.1002/acr.20183-
hcfmusp.relation.referencePrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189-
hcfmusp.relation.referenceQuartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254-
hcfmusp.relation.referenceRonaghy A, 2011, ANN RHEUM DIS, V70, P2037, DOI 10.1136/ard.2010.145151-
hcfmusp.relation.referenceSchmoeller D, 2009, PEDIATR INFECT DIS J, V28, P1037, DOI 10.1097/INF.0b013e3181bbc571-
hcfmusp.relation.referenceSexton K, 2009, ARCH DIS CHILD, V94, P224, DOI 10.1136/adc.2007.125195-
hcfmusp.relation.referenceShimizu M, 2012, CLIN VACCINE IMMUNOL, V19, P1700, DOI 10.1128/CVI.00309-12-
hcfmusp.relation.referenceShinoki T, 2012, MOD RHEUMATOL, V22, P871, DOI 10.1007/s10165-012-0595-z-
hcfmusp.relation.referenceShoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003-
hcfmusp.relation.referenceSilva CAA, 2010, REV BRAS REUMATOL, V50, P351, DOI 10.1590/S0482-50042010000400002-
hcfmusp.relation.referenceSinha R, 2005, ARCH DIS CHILD, V90, P891, DOI 10.1136/adc.2004.071332-
hcfmusp.relation.referenceToplak N, 2012, CLIN EXP RHEUMATOL, V30, P436-
hcfmusp.relation.referenceTorrelo A, 2006, PEDIATR DERMATOL, V23, P484, DOI 10.1111/j.1525-1470.2006.00289.x-
hcfmusp.relation.referenceUehara R, 2010, PEDIATR INFECT DIS J, V29, P430, DOI 10.1097/INF.0b013e3181cacede-
hcfmusp.relation.referenceUS Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2007, GUID IND CLIN DAT NE-
hcfmusp.relation.referenceWatanabe T, 2011, PEDIATR NEPHROL, V26, P795, DOI 10.1007/s00467-010-1722-8-
hcfmusp.relation.referenceWatanabe T, 2001, PEDIATR NEPHROL, V16, P458-
hcfmusp.relation.referenceWeinstein M, 2006, CAN MED ASSOC J, V174, P459, DOI 10.1503/cmaj.051211-
hcfmusp.relation.referenceZonneveld-Huijssoon E, 2007, ARTHRITIS RHEUM, V56, P639, DOI 10.1002/art.22399-
hcfmusp.remissive.sponsorshipFederico Foundation-
hcfmusp.remissive.sponsorshipFederico Foundation-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/ICr
Instituto da Criança - HC/ICr

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia

Artigos e Materiais de Revistas Científicas - LIM/36
LIM/36 - Laboratório de Pediatria Clínica

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)289.87 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.